CPIX
Cumberland Pharmaceuticals
NASDAQ · Pharmaceuticals
$3.91
+0.32 (+8.91%)
Open$3.54
Previous Close$3.59
Day High$3.98
Day Low$3.54
52W High$38.95
52W Low$17.55
Volume—
Avg Volume179.5K
Market Cap58.48M
P/E Ratio—
EPS$-1.15
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+806.6% upside
Current
$3.91
$3.91
Target
$35.45
$35.45
$27.92
$35.45 avg
$53.56
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.15M | 7.91M | 6.82M |
| Net Income | 1.22M | 1.22M | 1.20M |
| Profit Margin | 15.0% | 15.4% | 17.6% |
| EBITDA | 2.10M | 2.16M | 1.75M |
| Free Cash Flow | 768.5K | 556.1K | 718.5K |
| Rev Growth | +6.6% | +3.2% | +18.5% |
| Debt/Equity | 0.85 | 0.66 | 0.69 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |